IRON
Disc Medicine, Inc.
$80.06
+0.30 (+0.38%)
At close · Jul 8
Market Cap
$3.02B
Shares
38,199,089
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$80.06
Open$78.79
Day$77.00–80.22
52W$40.00–99.50
Avg vol 30d709K
Short int6.0M · 15.7% float · 14.1d
Short vol67%
Last earningsMay 5, 2026
DataAug 2020–Jul 2026
Filing10-Q · May 5
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Bearish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+8%
above
Price vs 50-day avg
+15%
above
RSI (14)
73
overbought
MACD trend
Positive
52-week position
67%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+22%
trailing
6-month return
+6%
trailing
YTD return
+1%
this year
Relative strength
−1%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $70 › 200d $74 — 200d above 50d
Institutional flow
Distributing
5 of 205 funds reported for Jun 30 · net -162.0K sh shares · +1 new
Insider flow
Distributing
Net -$841.3K over 90 days · 100% sells
Short interest
Rising
15.73% of float · ▲ +0.2% MoM · 14.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
205 holders — near 3-yr high, broad support
Squeeze score
81
high risk · 0–100
Fundamentals
EPS growth
−52%
Y/Y
Free cash flow
$-181.3M
Balance sheet
$62.0M
net cash
Quant / Vol
risk profile
Volatility
53%
annualized · 1-yr
Max drawdown
−41%
past year
ATR
4.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Aug 13, 2026
Est · unconfirmed
· in 5 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 5, 2026
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+8%
Bullish
Price vs 50-day avg
+15%
Bullish
RSI (14)
73
Bearish
MACD trend
Positive
Bullish
52-week position
67%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $70 › 200d $74 — 200d above 50d
Institutional flow
Distributing
5 of 205 funds reported for Jun 30 · net -162.0K sh shares · +1 new
Insider flow
Distributing
Net -$841.3K over 90 days · 100% sells
Short interest
Rising
15.73% of float · ▲ +0.2% MoM · 14.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
205 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $40
Now $80 · 67%
52-wk high $100
vs 200-day avg +8%
vs 50-day avg +15%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IRON
this stock
Disc Medicine, Inc.
|
$3.02B | +0.8% | — | — | 15.7% |
|
ONC
BeOne Medicines Ltd.
|
$437.67B | -0.6% | +22179.2% | 890.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.01B | +9.9% | +46.2% | 29.5 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$70.03B | -14.0% | +20.8% | 16.3 | 3.2% |
|
ARGX
Argenx SE
|
$56.84B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IRON | +9.5% | +21.7% | +6.1% | +9.5% | +0.8% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | +9.6% | +20.8% | -1.3% | +9.6% | -8.5% |